Loading...

FITC anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_FITC_1_110210
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_1_110210
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_2_110210
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
101205 50 µg 47 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101206 500 µg 132 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  2. Ostapoff K, et al. 2014. Cancer Res. 74:4966. PubMed
  3. Fan X, et al. 2015. Cancer Res. 75:86. PubMed
  4. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  5. Moreno-García Á, et al. 2020. Biomolecules. 10:00. PubMed
  6. Xue F, et al. 2020. Int J Biol Sci. 2.105555556. PubMed
  7. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  8. Kiepura A, et al. 2021. Int J Mol Sci. 22:. PubMed
  9. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  10. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  11. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  12. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  13. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  14. Nesseler JP, et al. 2020. Cancers (Basel). 12: . PubMed
  15. Song R, et al. 2022. Immunology. 165:274. PubMed
  16. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  17. He D, et al. 2022. Immunity. 55:159. PubMed
  18. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  19. Du Y, et al. 2022. FASEB J. 36:e22248. PubMed
  20. van Dierendonck XAMH, et al. 2022. Proc Natl Acad Sci U S A. 119:e2114739119. PubMed
  21. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  22. Liu X, et al. 2022. Adv Sci (Weinh). 9:e2105650. PubMed
  23. Usui-Ouchi A, et al. 2022. Glia. 70:1762. PubMed
  24. Ocaña-Guzman R, et al. 2022. Cells. 11: . PubMed
  25. Li J, et al. 2022. FASEB J. 36:e22400. PubMed
  26. Dong H, et al. 2022. Proc Natl Acad Sci U S A. 119:e2123247119. PubMed
  27. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  28. Komori R, et al. 2022. Int J Mol Sci. 23: . PubMed
  29. Ostendorf BN, et al. 2022. Nature. 611:346. PubMed
  30. Shen Z, et al. 2022. EBioMedicine. 85:104285. PubMed
  31. Xuan FL, et al. 2022. Front Immunol. 13:1005067. PubMed
  32. Foo CX, et al. 2023. Eur Respir J. 61: . PubMed
  33. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  34. Shang T, et al. 2022. Front Pharmacol. 13:1054176. PubMed
  35. Roy S, et al. 2022. Am J Cancer Res. 12:4977. PubMed
  36. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  37. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  38. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  39. Miró L, et al. 2022. Cancers (Basel). 14: . PubMed
  40. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  41. Chen L, et al. 2022. Cancer Immunol Immunother. :. PubMed
  42. Chan L, et al. 2022. Cells. 12: . PubMed
  43. Wang L, et al. 2022. Nutrients. 15: . PubMed
  44. Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed
  45. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  46. Li Y, et al. 2023. Cell Death Dis. 14:28. PubMed
  47. Freitag K, et al. 2023. Commun Biol. 6:40. PubMed
  48. Schmidt AD, et al. 2023. J Invest Dermatol. :. PubMed
  49. Jiang X, et al. 2023. Cell Discov. 9:7. PubMed
  50. Li B, et al. 2023. Nat Commun. 14:489. PubMed
  51. Schick J, et al. 2023. Elife. 12: . PubMed
  52. Zhu X, et al. 2023. Front Immunol. 14:1114802. PubMed
  53. Zhong CS, et al. 2022. Acta Pharmacol Sin. 43:1324. PubMed
  54. Mecklenburg J, et al. 2022. Brain Behav Immun. 101:246. PubMed
  55. Murotomi K, et al. 2022. Exp Biol Med (Maywood). 247:848. PubMed
  56. Zhao X, et al. 2022. Cell Mol Immunol. 19:540. PubMed
  57. Xin DQ, et al. 2022. Neural Regen Res. 17:2238. PubMed
  58. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  59. Tao X, et al. 2022. J Exp Med. 219:. PubMed
  60. Lopez R, et al. 2022. Nat Biotechnol. 40:1360. PubMed
  61. Gaikwad H, et al. 2022. ACS Nano. . PubMed
  62. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  63. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  64. Rybova J, et al. 2022. J Inherit Metab Dis. 45:1175. PubMed
  65. Chen Y, et al. 2022. Am J Cancer Res. 12:5286. PubMed
  66. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  67. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  68. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  69. Adzika GK, et al. 2023. Front Immunol. 14:1124649. PubMed
  70. Wang YC, et al. 2023. J Exp Med. 220:. PubMed
  71. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  72. Yang Y, et al. 2023. Cancers (Basel). 15:. PubMed
  73. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  74. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  75. Latour YL, et al. 2023. Gut Microbes. 15:2192623. PubMed
  76. Dona MSI, et al. 2023. Basic Res Cardiol. 118:11. PubMed
  77. Sun JY, et al. 2023. Sci Adv. 9:eade4110. PubMed
  78. Iguchi A, et al. 2023. iScience. 26:106375. PubMed
  79. Han S, et al. 2023. Int J Mol Sci. 24:. PubMed
  80. Zhu CL, et al. 2023. Int J Biol Sci. 19:1413. PubMed
  81. Thai LM, et al. 2023. iScience. 26:106477. PubMed
  82. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  83. Banka AL, et al. 2023. Nat Commun. 14:2462. PubMed
  84. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  85. Qin C, et al. 2023. iScience. 26:106588. PubMed
  86. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  87. Xu Y, et al. 2023. J Cancer. 14:1182. PubMed
  88. Feng X, et al. 2023. Nat Commun. 14:3208. PubMed
  89. Zhang Y, et al. 2023. NPJ Regen Med. 8:28. PubMed
  90. Chen SW, et al. 2023. Methods Mol Biol. 2683:53. PubMed
  91. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  92. Mawambo G, et al. 2023. J Neuroinflammation. 20:145. PubMed
  93. Gupta P, Rajan M, Kulkarni S, et al. 2017. Int Immunopharmacol. 10.1016/j.intimp.2017.06.025. PubMed
  94. Haimon Z et al. 2018. Nature immunology. 19(6):636-644 . PubMed
  95. Bijland S, et al. 2019. F1000Res. 8:117. PubMed
  96. Furuhashi K, et al. 2017. Immunology. 151:227. PubMed
  97. Miyatake Y, et al. 2018. J Immunol. 201:3051. PubMed
  98. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  99. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  100. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  101. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  102. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  103. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  104. Belmonte L, et al. 2016. Sci Rep. 6:35813. PubMed
  105. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  106. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  107. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  108. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  109. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  110. Gan C, et al. 2022. Respir Res. 23:32. PubMed
  111. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  112. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  113. Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed
  114. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  115. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  116. Fu R, et al. 2020. Sci Rep. 10:1455. PubMed
  117. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  118. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  119. Bo Yu et al. 2018. Cell stem cell. 23(2):193-209 . PubMed
  120. Shavit Stein E, et al. 2018. Neural Plast. 2018:7692182. PubMed
  121. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  122. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  123. Tu S, et al. 2020. Cellular Signalling. 73:109695. PubMed
  124. Pandey S, et al. 2020. Cell Syst. 11:495. PubMed
  125. Tuominen S, et al. 2021. Eur J Nucl Med Mol Imaging. 48:1312. PubMed
  126. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  127. Poli V, et al. 2021. iScience. 24:103256. PubMed
  128. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  129. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  130. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  131. Zhu ZY, et al. 2022. Front Immunol. 12:781087. PubMed
  132. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  133. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  134. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  135. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  136. Chen S, et al. 2022. Cancer Discov. :. PubMed
  137. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  138. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  139. Zhang YS, et al. 2018. Cancer Biol Ther. 19:735. PubMed
  140. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  141. Wu G, et al. 2020. Front Oncol. 10:194. PubMed
  142. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  143. Lin R, et al. 2020. Sci Rep. 10:14397. PubMed
  144. Koning B, et al. 2006. Int Immunol. 1.403472222. PubMed
  145. Kapadia D, et al. 2011. PLoS One. 6:e19376. PubMed
  146. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  147. Stahnke S, et al. 2021. Current Biology. 31(10):2051-2064.e8. PubMed
  148. Zhang S, et al. 2021. Cell. 184(8):2151-2166.e16. PubMed
  149. Yousif AS, et al. 2020. Immunity. 54(2):235-246.e5. PubMed
  150. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  151. Duan M, et al. 2022. Cell Commun Signal. 20:60. PubMed
  152. Zhang Q, et al. 2021. Theranostics. 11:8301. PubMed
  153. Li B, et al. 2022. iScience. 25:103772. PubMed
  154. DeMarco JK, et al. 2021. Vaccines (Basel). 9:. PubMed
  155. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  156. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  157. Tong X, et al. 2020. Front Pharmacol. 1.404166667. PubMed
  158. Shang W, et al. 2019. J Diabetes Res. 2019:5641271. PubMed
  159. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  160. Lindborg JA et al. 2017. The Journal of Neuroscience. 37(43):10258-10277 . PubMed
  161. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  162. Caiado F, et al. 2013. Cancer Res. 73:4233. PubMed
  163. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  164. Esmaili S, et al. 2021. Cell Systems. 12(5):432-445.e7. PubMed
  165. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  166. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  167. Yang C, et al. 2020. J Control Release. 326:324. PubMed
  168. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  169. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  170. Tanner MA, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H633. PubMed
  171. Kasper M, et al. 2021. Elife. 10:. PubMed
  172. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  173. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  174. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  175. Siew JJ, et al. 2019. Nat Commun. 10:3473. PubMed
  176. Verma M, et al. 2018. Brain Behav Immun. 69:223. PubMed
  177. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  178. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  179. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  180. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  181. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  182. Periasamy S, et al. 2011. J Leukoc Biol. 90:493. PubMed
  183. Kan C, et al. 2022. Bone Res. 10:62. PubMed
  184. Zhang J, et al. 2021. J Leukoc Biol. 110:485. PubMed
  185. Qiu F, et al. 2022. J Cancer. 13:2893. PubMed
  186. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  187. Hou H, et al. 2021. Front Cell Dev Biol. 9:737003. PubMed
  188. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  189. Liang P, et al. 2022. Mol Biomed. 3:14. PubMed
  190. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  191. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  192. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  193. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  194. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  195. Luo W, et al. 2019. Mol Med Rep. 20:1007. PubMed
  196. Mayers S, et al. 2019. BMC Biotechnol. 19:21. PubMed
  197. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  198. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  199. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  200. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  201. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  202. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  203. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  204. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  205. Shen Y, et al. 2022. CNS Neurosci Ther. 28:46. PubMed
  206. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  207. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  208. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  209. Zong Z, et al. 2019. Front Immunol. 10:1643. PubMed
  210. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  211. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  212. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  213. Marks KE, et al. 2021. Cell Reports. 35(13):109303. PubMed
  214. Ohgomori T, et al. 2020. Neuropharmacology. 176:108227. PubMed
  215. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  216. Köchl R, et al. 2020. Elife. 9:00. PubMed
  217. Lin D, et al. 2015. Proc Natl Acad Sci U S A. 112: 11324-11329. PubMed
  218. Madan-Lala R, et al. 2014. J Immunol. 192:4263. PubMed
  219. Ippolito G, et al. 2014. Proc Natl Acad Sci U S A. 111:998. PubMed
  220. Yuan F, et al. 2022. Front Immunol. 13:798583. PubMed
  221. Forbester JL, et al. 2020. J Virol. 94:. PubMed
  222. Wu H, et al. 2022. Biomolecules. 12:. PubMed
  223. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  224. Gao H, et al. 2021. Cells. 10:. PubMed
  225. Saitoh BY, et al. 2021. Brain Behav Immun. 95:362. PubMed
  226. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  227. Perez–Zsolt D, et al. 2019. Front Immunol. 0.989583333. PubMed
  228. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  229. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  230. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  231. Ye Z, et al. 2019. Mediators Inflamm. 2019:8709583. PubMed
  232. Tan A, et al. 2012. Mol Pharmacol. 9:2710. PubMed
  233. Cappello P, et al. 2013. Gastroenterology. 144:1098. PubMed
  234. Meraz I, et al. 2014. PLoS One. 9:94703. PubMed
  235. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  236. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  237. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  238. Koivisto CS, et al. 2020. Neoplasia. 1.252777778. PubMed
  239. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  240. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  241. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  242. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  243. Dong S, et al. 2021. Nature. 591:117. PubMed
  244. Dang Y, et al. 2021. J Cancer. 12:7158. PubMed
  245. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  246. Yadav P, et al. 2021. J Immunol. 206:2888. PubMed
  247. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  248. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  249. Bao C, et al. 2021. Infect Immun. 89:. PubMed
  250. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  251. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  252. Wang F, et al. 2018. Carcinogenesis. 39:889. PubMed
  253. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  254. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  255. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  256. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  257. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  258. Yee PP, et al. 2020. Nat Commun. 4.225. PubMed
  259. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  260. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  261. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  262. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  263. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  264. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  265. Shiraki N, et al. 2022. Stem Cell Reports. 17:221. PubMed
  266. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  267. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  268. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  269. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  270. Wang Q, et al. 2018. Nat Commun. 9:559. PubMed
  271. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  272. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  273. Miller S, et al. 2016. Acta Biochim Biophys Sin. 48: 334-341. PubMed
  274. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  275. Riedelberger M, et al. 2020. Bio Protoc. e3552:10. PubMed
  276. Cho K, et al. 2021. iScience. 24:103117. PubMed
  277. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  278. Bakker W, et al. 2021. Int J Mol Sci. 22:. PubMed
  279. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  280. Shan C, et al. 2021. Front Immunol. 12:766401. PubMed
  281. Sobecki M, et al. 2021. Nat Commun. 12:4700. PubMed
  282. Nishida J, et al. 2022. STAR Protoc. 3:101306. PubMed
  283. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  284. Lei J, et al. 2021. Theranostics. 4251:11. PubMed
  285. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  286. Chen X, et al. 2016. PLoS One. 11:e0168861. PubMed
  287. Uto T, et al. 2016. Nat Commun. 7: 11273. PubMed
  288. Leon-Rico D, et al. 2015. Lab Anim. 49:132. PubMed
  289. Dong L, et al. 2022. Cells. 11:. PubMed
  290. Li Y, et al. 2022. Front Cardiovasc Med. 9:830781. PubMed
  291. Tang C, et al. 2021. Theranostics. 11:9791. PubMed
  292. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  293. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  294. Sun S, et al. 2021. Front Immunol. 12:777665. PubMed
  295. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  296. Simões FC, et al. 2020. Nat Commun. 0.875. PubMed
  297. Ku AT et al. 2017. eLife. 6 pii: e23242. PubMed
  298. Ding X, et al. 2015. J Immunol. 194:4251. PubMed
  299. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  300. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  301. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  302. Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed
  303. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
  304. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  305. Liu P, et al. 2022. iScience. 25:103867. PubMed
  306. Vasudevan SO, et al. 2022. Cell Rep. 39:110755. PubMed
  307. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  308. Niemi JP, et al. 2020. Methods Mol Biol. 2143:207. PubMed
  309. Dionisio-Santos DA, et al. 2021. Front Neurosci. 15:758677. PubMed
  310. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  311. Jäger M, et al. 2018. Antioxid Redox Signal. 30. PubMed
  312. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  313. Liu D, et al. 2020. Front Pharmacol. 11:204. PubMed
  314. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  315. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  316. Dong R, et al. 2021. Frontiers in Immunology. 12:620238. PubMed
  317. Chen S, et al. 2020. Allergy Asthma Immunol Res. 0.922222222. PubMed
  318. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  319. Chen F, et al. 2016. J Immunol. 196: 4390 - 4399. PubMed
  320. Stevenson ER, et al. 2022. J Pharmacol Exp Ther. 382:356. PubMed
  321. Chen Y, et al. 2022. Life Sci. 306:120826. PubMed
  322. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  323. Zhuo Y, et al. 2018. Oncol Rep. 40:2147. PubMed
  324. Ponzetta A, et al. 2020. Cell. 178(2):346-360.e24.. PubMed
  325. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  326. Lima-Junior D, et al. 2017. J Immunol. 10.4049/jimmunol.1700258. PubMed
  327. Ostapoff K, et al. 2013. Mol Cancer Ther. 12:1190. PubMed
  328. Macagno M, et al. 2014. J Immunol. 192:5434. PubMed
  329. Chou H, et al. 2015. Proc Natl Acad Sci U S A. 112:2175. PubMed
  330. Quan S, et al. 2015. J Immunol. 194:4175. PubMed
  331. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  332. Yamamuro T, et al. 2020. Nat Commun. 3.340277778. PubMed
  333. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  334. He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
  335. Hua X, et al. 2021. Front Immunol. 12:706027. PubMed
  336. Feng L, et al. 2022. Signal Transduct Target Ther. 7:21. PubMed
  337. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  338. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  339. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  340. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  341. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  342. Ohgomori T et al. 2019. J Comp Neurol. 528(1):14-31 . PubMed
  343. Li S, et al. 2019. Front Neurol. 1.036805556. PubMed
  344. Li K, et al. 2020. J Cell Mol Med. 24:13115. PubMed
  345. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  346. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  347. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  348. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  349. Zhang GL, et al. 2020. Matrix Biol. 93:25. PubMed
  350. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  351. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  352. Mihalik NE, et al. 2021. AAPS PharmSciTech. 22:191. PubMed
  353. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  354. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  355. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  356. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  357. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  358. Kitamura K, et al. 2019. Int J Cardiol Heart Vasc. 23:100344. PubMed
  359. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  360. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  361. Alter C et al. 2019. Am J Physiol Heart Circ Physiol. 317(1):H190-H200 . PubMed
  362. Spolski R et al. 2019. Elife. 8 pii: e45501. PubMed
  363. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  364. Erin N, et al. 2015. Brain Behav Immun. 48: 174-185. PubMed
  365. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  366. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  367. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  368. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  369. Adzika GK, et al. 2021. Front Cell Dev Biol. 9:719351. PubMed
  370. Tang S, et al. 2022. Virol J. 19:32. PubMed
  371. Cui Y, et al. 2022. Front Oncol. 12:732860. PubMed
  372. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  373. Tähtinen S, et al. 2022. Nat Immunol. 23:532. PubMed
  374. Patel C, et al. 2022. Curr Protoc. 2:e400. PubMed
  375. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  376. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  377. Glodde N et al. 2017. Immunity. 47(4):789-802 . PubMed
  378. Fox D, et al. 2020. Nat Commun. 0.986111111. PubMed
  379. Deng M, et al. 2019. J Exp Med. 216:2838. PubMed
  380. Chan JY, et al. 2019. Diabetologia. 62:993. PubMed
  381. Liu SS, et al. 2021. Immunity. :. PubMed
  382. Zhou JH, et al. 2020. Onco Targets Ther. 7.278472222. PubMed
  383. Sitapara RA, et al. 2020. Mol Med. 26:63. PubMed
  384. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  385. Zhong B, et al. 2013. Sci Signal. 6:35. PubMed
  386. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  387. Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed
  388. Wang X, et al. 2022. Elife. 11:. PubMed
  389. Adzika GK, et al. 2021. Front Cardiovasc Med. 8:719805. PubMed
  390. Chen X, et al. 2021. Cell Death Dis. 12:1123. PubMed
  391. Chen J, et al. 2021. Oncol Lett. 21:409. PubMed
  392. Woods B, et al. 2019. Clin Cancer Res. 25:5901. PubMed
  393. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  394. Calvente CJ, et al. 2019. J Clin Invest. 130:4091. PubMed
  395. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  396. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  397. Uehara M, et al. 2019. Sci Rep. 9:6535. PubMed
  398. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  399. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  400. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  401. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  402. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  403. Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed
  404. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  405. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  406. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  407. Palma A, et al. 2022. Front Cell Dev Biol. 10:841548. PubMed
  408. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  409. Bartley A, et al. 2018. Front Physiol. 9:1593. PubMed
  410. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
  411. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  412. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  413. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  414. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  415. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  416. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  417. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  418. Koronyo Y, et al. 2015. Brain. 138: 2399-2422. PubMed
  419. Zhao Y, et al. 2013. J Leukoc Biol. 94:1103. PubMed
  420. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  421. Wang S, et al. 2022. Blood. 140:171. PubMed
  422. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  423. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  424. Wu KKL, et al. 2021. Nat Commun. 12:6637. PubMed
  425. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  426. Xue Y, et al. 2020. Sci Rep. 10:22265. PubMed
  427. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  428. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  429. Moriyasu T, et al. 2018. PLoS Negl Trop Dis. 12:e0006197. PubMed
RRID
AB_312788 (BioLegend Cat. No. 101205)
AB_312788 (BioLegend Cat. No. 101206)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD11b
Specificity Alt (DOES NOT SHOW ON TDS):
CD11b
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about CD11b on UniProt.org

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account